Cogstate Posts Higher Fiscal H1 Revenue, Clinical Trial Contract Value; Shares Up 7%

MT Newswires Live

01/22

Cogstate (ASX:CGS) reported total revenue of $26.9 million and executed $41.7 million of clinical trial sales contracts for the six months ended Dec. 31, 2025, according to a Thursday filing with the Australian bourse.

The company posted revenue of $23.9 million and executed net clinical trial sales contracts of $20.3 million for the six months ended Dec. 31,2024, an earlier filing showed.

The company now expects its fiscal 2026 earnings before interest, taxes, depreciation and amortization margin to be at the top end of the 20% to 23% range, the filing said.

Shares of the company rose past 7% in recent Thursday trade.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2605437866"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2605437866\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2605437866?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-22 08:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2605437866","market":"sg","top_or_hot":-1,"title":"Cogstate Posts Higher Fiscal H1 Revenue, Clinical Trial Contract Value; Shares Up 7%","media":"MT Newswires Live","content":"<html><body><p> Cogstate (ASX:CGS) reported total revenue of $26.9 million and executed $41.7 million of clinical trial sales contracts for the six months ended Dec. 31, 2025, according to a Thursday filing with the Australian bourse.</p><p>The company posted revenue of $23.9 million and executed net clinical trial sales contracts of $20.3 million for the six months ended Dec. 31,2024, an earlier filing showed.</p><p>The company now expects its fiscal 2026 earnings before interest, taxes, depreciation and amortization margin to be at the top end of the 20% to 23% range, the filing said.</p><p>Shares of the company rose past 7% in recent Thursday trade.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cogstate Posts Higher Fiscal H1 Revenue, Clinical Trial Contract Value; Shares Up 7%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCogstate Posts Higher Fiscal H1 Revenue, Clinical Trial Contract Value; Shares Up 7%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-01-22 08:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Cogstate (ASX:CGS) reported total revenue of $26.9 million and executed $41.7 million of clinical trial sales contracts for the six months ended Dec. 31, 2025, according to a Thursday filing with the Australian bourse.</p><p>The company posted revenue of $23.9 million and executed net clinical trial sales contracts of $20.3 million for the six months ended Dec. 31,2024, an earlier filing showed.</p><p>The company now expects its fiscal 2026 earnings before interest, taxes, depreciation and amortization margin to be at the top end of the 20% to 23% range, the filing said.</p><p>Shares of the company rose past 7% in recent Thursday trade.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CGS.AU","symbol_name":"COGSTATE LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2605437866","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2605437866","pubTimestamp":1769043263,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Cogstate  reported total revenue of $26.9 million and executed $41.7 million of clinical trial sales contracts for the six months ended Dec. 31, 2025, according to a Thursday filing with the Australian bourse.The company posted revenue of $23.9 million and executed net clinical trial sales contracts of $20.3 million for the six months ended Dec. 31,2024, an earlier filing showed.The company now expects its fiscal 2026 earnings before interest, taxes, depreciation and amortization margin to be at the top end of the 20% to 23% range, the filing said.Shares of the company rose past 7% in recent Thursday trade.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CGS.AU":"COGSTATE LTD","BK7094":"医疗保健技术"},"translate_title":"Cogstate公布上半年财政收入、临床试验合同价值更高；股价上涨7%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGS.AU":1},"content_text":"Cogstate (ASX:CGS) reported total revenue of $26.9 million and executed $41.7 million of clinical trial sales contracts for the six months ended Dec. 31, 2025, according to a Thursday filing with the Australian bourse.The company posted revenue of $23.9 million and executed net clinical trial sales contracts of $20.3 million for the six months ended Dec. 31,2024, an earlier filing showed.The company now expects its fiscal 2026 earnings before interest, taxes, depreciation and amortization margin to be at the top end of the 20% to 23% range, the filing said.Shares of the company rose past 7% in recent Thursday trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}